You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

May 15, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Greatest impact of pharmacist transition care seen in elderly

A care transition program for hospital patients with bedside delivery of postdischarge medications and follow-up calls by pharmacists shortly after discharge had the greatest impact on elderly patients, resulting in a lower likelihood of 30-day readmission, according to a report published May 1 in the American Journal of Health-System Pharmacy. » More

Report: Dabigatran moves from mother to fetus

New research published in Obstetrics & Gynecology indicates the oral thrombin inhibitor, dabigatran, and its prodrug, dabigatran etexilate mesylate transfer from pregnant women to their fetuses via the placenta and could potentially affect fetal blood coagulation.
» More

Pharmacists reduce Rx errors in HIV patients

A pharmacist’s participation on medical teams treating HIV-positive hospital patients reduces medication errors as well as spots and corrects them sooner, according to a report published in the Annals of Pharmacotherapy. » More

FDA approves clot-busting vorapaxar

FDA approved vorapaxar (Zontivity, Merck Sharp &Dohme Corp., a subsidiary of Merck) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart attack or blockages in the arteries to the legs. » More

Continuing Education

MTM essentials for hypertension—Part 2: Drug therapy considerations

This month's article is the fourth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss place in therapy of drug classes used to treat hypertension and review drug considerations of prescription antihypertensive mediations and herbal supplements that are relevant to medication therapy management of hypertension.

To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to log in.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

 

Check these out, too

Drug combo severely reduces UTIs in kids

NACDS Foundation announces grants

Fiber intake after MI reduces death risk

Pharmacy owner guilty in repackaging plot

Voices

Anticoagulation Update

JP at Large

View from the Zoo

Viewpoints

Regulatory and Legal

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group